These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29212257)

  • 1. Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells.
    Zhao G; Wang Q; Gu Q; Qiang W; Wei JJ; Dong P; Watari H; Li W; Yue J
    Oncotarget; 2017 Nov; 8(55):94666-94680. PubMed ID: 29212257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway.
    Wang B; Li X; Zhao G; Yan H; Dong P; Watari H; Sims M; Li W; Pfeffer LM; Guo Y; Yue J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):235. PubMed ID: 30241553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of survivin results in inhibition of epithelial to mesenchymal transition in retinal pigment epithelial cells by attenuating the TGFβ pathway.
    Zhang P; Zhao G; Ji L; Yin J; Lu L; Li W; Zhou G; Chaum E; Yue J
    Biochem Biophys Res Commun; 2018 Apr; 498(3):573-578. PubMed ID: 29522718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockout of MTF1 Inhibits the Epithelial to Mesenchymal Transition in Ovarian Cancer Cells.
    Ji L; Zhao G; Zhang P; Huo W; Dong P; Watari H; Jia L; Pfeffer LM; Yue J; Zheng J
    J Cancer; 2018; 9(24):4578-4585. PubMed ID: 30588241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway.
    Zhao G; Zhang W; Dong P; Watari H; Guo Y; Pfeffer LM; Tigyi G; Yue J
    Cell Biosci; 2021 Apr; 11(1):70. PubMed ID: 33827661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells.
    Huo W; Zhao G; Yin J; Ouyang X; Wang Y; Yang C; Wang B; Dong P; Wang Z; Watari H; Chaum E; Pfeffer LM; Yue J
    J Cancer; 2017; 8(1):57-64. PubMed ID: 28123598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral vector mediated-ASAP1 expression promotes epithelial to mesenchymal transition in ovarian cancer cells.
    Zhang T; Zhao G; Yang C; Dong P; Watari H; Zeng L; Pfeffer LM; Yue J
    Oncol Lett; 2018 Apr; 15(4):4432-4438. PubMed ID: 29541211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Luminacin D Analog HL142 Inhibits Ovarian Tumor Growth and Metastasis by Reversing EMT and Attenuating the TGFβ and FAK Pathways.
    Wang B; Li H; Zhao X; Zhang W; Zhao G; Wu Z; Zhang R; Dong P; Watari H; Tigyi G; Li W; Yue J
    J Cancer; 2021; 12(18):5654-5663. PubMed ID: 34405025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockout Of
    Narimani M; Sharifi M; Jalili A
    Blood Lymphat Cancer; 2019; 9():53-61. PubMed ID: 31819702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
    Lee SC; Kim OH; Lee SK; Kim SJ
    Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
    Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
    Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline inducible Krüppel-like factor 4 lentiviral vector mediates mesenchymal to epithelial transition in ovarian cancer cells.
    Chen Z; Wang Y; Liu W; Zhao G; Lee S; Balogh A; Zou Y; Guo Y; Zhang Z; Gu W; Li C; Tigyi G; Yue J
    PLoS One; 2014; 9(8):e105331. PubMed ID: 25137052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian Primary and Metastatic Tumors Suppressed by Survivin Knockout or a Novel Survivin Inhibitor.
    Zhao G; Wang Q; Wu Z; Tian X; Yan H; Wang B; Dong P; Watari H; Pfeffer LM; Guo Y; Li W; Yue J
    Mol Cancer Ther; 2019 Dec; 18(12):2233-2245. PubMed ID: 31515295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian Cancer.
    Zhao G; Guo Y; Chen Z; Wang Y; Yang C; Dudas A; Du Z; Liu W; Zou Y; Szabo E; Lee SC; Sims M; Gu W; Tillmanns T; Pfeffer LM; Tigyi G; Yue J
    J Cancer Sci Ther; 2015; 7(2):34-43. PubMed ID: 26819680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KDM5A promotes proliferation and EMT in ovarian cancer and closely correlates with PTX resistance.
    Feng T; Wang Y; Lang Y; Zhang Y
    Mol Med Rep; 2017 Sep; 16(3):3573-3580. PubMed ID: 28714030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BIRC5: A novel therapeutic target for lung cancer stem cells and glioma stem cells.
    Kahm YJ; Kim RK
    Biochem Biophys Res Commun; 2023 Nov; 682():141-147. PubMed ID: 37806253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of galectin-1 by TLR-dependent PI3K activation enhances epithelial-mesenchymal transition of metastatic ovarian cancer cells.
    Park GB; Chung YH; Kim D
    Oncol Rep; 2017 May; 37(5):3137-3145. PubMed ID: 28350104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.